These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1337 related items for PubMed ID: 19886324

  • 1. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA.
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [Abstract] [Full Text] [Related]

  • 2. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 3. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(4):363-71. PubMed ID: 18569908
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Jul; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 5. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ, Lin MY, Chen HC, Hwang SC, Yang WC, Hsu CC, Chiu HC, Mau LW.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [Abstract] [Full Text] [Related]

  • 6. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA.
    Ren Fail; 2010 Oct; 32(8):954-8. PubMed ID: 20722563
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD.
    Nephron Clin Pract; 2008 Oct; 109(3):c109-18. PubMed ID: 18663322
    [Abstract] [Full Text] [Related]

  • 8. Age affects outcomes in chronic kidney disease.
    O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS.
    J Am Soc Nephrol; 2007 Oct; 18(10):2758-65. PubMed ID: 17855638
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 12. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 13. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D.
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):105-12. PubMed ID: 17200050
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mortality risk stratification in chronic kidney disease: one size for all ages?
    O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC.
    J Am Soc Nephrol; 2006 Mar; 17(3):846-53. PubMed ID: 16452492
    [Abstract] [Full Text] [Related]

  • 16. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Mar; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 17. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A, CKD-JAC Study Group.
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [Abstract] [Full Text] [Related]

  • 18. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jun; 30(1):67-72. PubMed ID: 18197546
    [Abstract] [Full Text] [Related]

  • 19. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 20. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.